Refractory discoid lupus erythematosus: response to efalizumab.
Rodríguez-Lojo
R
R
Paradela
S
S
Martínez-Gómez
W
W
Fernández-Torres
R
R
Fonseca
E
E
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002464:Cell Migration Inhibition / Q000187:drug effects*; D005260:Female; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy*; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab